The global Research and Development Centre for Life Science
Olympus, which recently opened the global Research and Development Centre for Life Science in Munich, will invest around euro 15m in this project.
By 2009, the centre will employ an estimated 450 people, bringing together a highly-qualified team from many fields for interdisciplinary work. Dr Helmut Köhler, Executive Managing Director of Olympus Life Science Europa GmbH and Olympus Life Science Research Europa GmbH, said that, in addition to early disease detection, the company’s objective is individualised disease prevention, analysis and prevention along with follow-up treatment. The Munich centre will focus on taking in vitro diagnostics, laboratory automation, molecular biology, digital image processing and microscopy applications to the next level.
Over the last four years, in the European life sciences sector, Olympus has achieved growth rates averaging 15.8% in microscopy and 10.4% in diagnostics, placing the firm as one of the leading companies in these markets. Tsuyoshi Kikukawa, President of the Olympus Corporation, added: ‘With our new global Research and Development Centre in Munich we have created the foundation for future sustained grown in this business segment.’
This article was published on 04/30/2008
Search
Service
Company News
Carestream: technical infrastructure for EU funded R-bay project
Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.
Accu-Chek® Combo – put effective diabetes management into action
At the annual congress of the European Association for the Study of Diabetes (EASD) this year in Rome, Roche Diabetes Care introduced Accu-Chek Combo – the insulin pump system that combines an insulin pump with an intelligent glucose monitoring system, a bolus calculator, and an integrated pump remote-control.
Insulin in oral capsules
At the international congress on diabetes in September, Oramed Pharmaceuticals, Inc. introduced its oral insulin capsules that might in the future replace injections patients currently have to face. Last week Oramed announced the agreement with ETI Karle Clinical Pvt. Ltd. to conduct phase 2B clinical trials for its oral insulin capsules.
.jpg&contenttype=jpeg)
